ArticleMikrochimica acta2026
Enhanced online preconcentration and enantioseparation of MOF-coated capillary electrochromatography for chiral derivatized aromatic amino acids.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Conventional enantioseparation approaches of aromatic amino acids (AAAs) commonly suffer from inherent limitations, including insufficient detection sensitivity, poor enantioselectivity, and inefficient analyte preconcentration, which severely restrict their application in trace-level determinations. We rationally designed a metal-organic framework (MOF)-modified capillary electrochromatography (CEC) system by integrating MIL-140 C as an efficient enrichment material and HQA-MOF as a high-performance chiral stationary phase. This integrated platform achieved up to 120-fold analyte enrichment and a low limit of detection (LOD) of 12.5 ng/mL, exhibiting significantly improved detection sensitivity, chiral resolution, and method reproducibility compared to traditional strategies. Method validation in spiked bovine serum albumin (BSA) samples demonstrated satisfactory recoveries ranging from 92.35% to 108.04%. The established MOF-CEC strategy provides a highly sensitive, selective, and scalable analytical tool for the precise chiral determination of trace Dansylated Aromatic Amino Acids (DNS-AAAs) in simulated biological samples.
Indexed as
Identifiers
42176201What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.